Physician profile
Michael G Gartlan
NPI 1740263664
$1,982.19
in general payments reported to CMS, 2019-2025
15 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $202 · 2021: $395 · 2022: $148 · 2023: $161 · 2024: $244 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $584.30 | 2019-2021 | |
| Acclarent, INC | $361.86 | 2019-2023 | Trudi Nav Cable |
| Medtronic, INC. | $342.27 | 2021-2025 | Propel, Stealthstation S8 Platform |
| Ethicon US, LLC | $137.09 | 2019 | |
| Stryker Corporation | $110.17 | 2019-2022 | |
| Smith+Nephew, INC. | $100.31 | 2021-2024 | |
| Optinose US, INC. | $71.92 | 2020-2021 | |
| Genzyme Corporation | $53.38 | 2021-2023 | |
| Glaxosmithkline, LLC. | $51.89 | 2022 | |
| Ambu INC. | $44.45 | 2020 | |
| Novartis Pharmaceuticals Corporation | $43.30 | 2019 | |
| Medical Device Business Services, INC. | $34.10 | 2019 | |
| Alk-Abello, INC | $22.05 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.06 | 2019 | |
| Olympus America INC. | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gartlan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.